Noom introduces longevity-focused GLP-1 microdosing with at-home biomarker tracking

Noom just expanded beyond weight loss with Proactive Health Microdose GLP-1, a new program aiming to support long-term metabolic health before chronic conditions take hold.

Prevention meets precision

Instead of relying on traditional weight-loss protocols, Noom uses GLP-1 microdoses at just 25% of the standard starting dose — to target key markers of metabolic function. Each planpairs three components:

1. Personalized microdoses of GLP-1 medication
2. Quarterly at-home blood tests tracking 17 biomarkers
3. Daily support through Noom’s digital platform for building sustainable habits.

The three parts of Noom’s Proactive Health Microdose GLP-1 program.

Inside the test

The quarterly at-home blood test covers a wide range of indicators:

• ApoB & Lp(a): Advanced heart disease predictors
• HbA1c: Blood sugar control and prediabetes detection
• hs-CRP: Silent inflammation linked to heart disease
• DHEA-S, Testosterone, Estradiol: Hormonal balance
• Vitamin D and B12: Key nutrients for metabolism

Results appear in the Noom app within a week, translated into actionable insights rather than medical jargon or confusing ranges.
Dr. Jeffrey Egler, Noom’s Chief Medical Officer, points out that three in four American adults in midlife alive with at least one chronic condition. The goal, he says is early detection — identifying risk while markers still appear “normal.”

“GLP-1s are not a shortcut, they’re the spark,” explains Dr. Egler. “They open the door for change, but actively walking through that door is what makes the transformation last.”

Who can join

The program is open to users with a BMI of 21 or higher. To enroll, you’ll complete a body photo, ID verification, intake questionnaire, and virtual doctor consultation for eligibility.

Where to buy

Proactive Health Microdose GLP-1Rx is available now for eligible Noom members at $149 per month through the Noom platform.